Literature DB >> 16055628

Deaths certified as asthma and use of medical services: a national case-control study.

P M Sturdy1, B K Butland, H R Anderson, J G Ayres, J M Bland, B D W Harrison, C Peckitt, C R Victor.   

Abstract

BACKGROUND: Studies have linked asthma death to either increased or decreased use of medical services.
METHODS: A population based case-control study of asthma deaths in 1994-8 was performed in 22 English, six Scottish, and five Welsh health authorities/boards. All 681 subjects who died were under the age of 65 years with asthma in Part I on the death certificates. After exclusions, 532 hospital controls were matched to 532 cases for age, district, and date of asthma admission/death. Data were extracted blind from primary care records.
RESULTS: The median age of the subjects who died was 53 years; 60% of cases and 64% of controls were female. There was little difference in outpatient attendance (55% and 55%), hospital admission for asthma (51% and 54%), and median inpatient days (20 days and 15 days) in the previous 5 years. After mutual adjustment and adjustment for sex, using conditional logistic regression, three variables were independently associated with asthma death: fewer general practice contacts (odds ratio 0.82 (95% confidence interval (CI) 0.74 to 0.91) per 5 contacts) in the previous year, more home visits (1.14 (95% CI 1.08 to 1.21) per visit) in the previous year, and fewer peak expiratory flow recordings (0.83 (95% CI 0.74 to 0.92) per occasion) in the previous 3 months. These associations were similar after adjustment for markers of severity, psychosocial factors, systemic steroids, short acting bronchodilators and antibiotics, although the association with peak flow was weakened and just lost significance.
CONCLUSION: Asthma death is associated with less use of primary care services. Both practice and patient factors may be involved and a better understanding of these may offer possibilities for reducing asthma death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055628      PMCID: PMC1747248          DOI: 10.1136/thx.2004.025593

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  A confidential enquiry into certified asthma deaths in the North of England, 1994-96: influence of co-morbidity and diagnostic inaccuracy.

Authors:  K Jones; W T Berrill; C L Bromly; D J Hendrick
Journal:  Respir Med       Date:  1999-12       Impact factor: 3.415

2.  Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Wendy Ferris; Dean Fergusson; Elizabeth Tullis; David Haase; Yves Berthiaume; Neil Brown; Pearce Wilcox; Veronica Yozghatlian; Peter Bye; Scott Bell; Francis Chan; Barbara Rose; Alphonse Jeanneret; Anne Stephenson; Mary Noseworthy; Andreas Freitag; Nigel Paterson; Steve Doucette; Colin Harbour; Michel Ruel; Noni MacDonald
Journal:  Lancet       Date:  2005 Aug 6-12       Impact factor: 79.321

3.  Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.

Authors:  J Grainger; K Woodman; N Pearce; J Crane; C Burgess; A Keane; R Beasley
Journal:  Thorax       Date:  1991-02       Impact factor: 9.139

4.  Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study.

Authors:  P M Sturdy; C R Victor; H R Anderson; J M Bland; B K Butland; B D W Harrison; C Peckitt; J C Taylor
Journal:  Thorax       Date:  2002-12       Impact factor: 9.139

5.  Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack.

Authors:  J Kolbe; W Fergusson; M Vamos; J Garrett
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

6.  Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.

Authors:  J Crane; N Pearce; A Flatt; C Burgess; R Jackson; T Kwong; M Ball; R Beasley
Journal:  Lancet       Date:  1989-04-29       Impact factor: 79.321

7.  A district confidential enquiry into deaths due to asthma.

Authors:  N J Wareham; B D Harrison; P F Jenkins; J Nicholls; D E Stableforth
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

8.  Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.

Authors:  N Pearce; J Grainger; M Atkinson; J Crane; C Burgess; C Culling; H Windom; R Beasley
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

9.  A comparison of asthma deaths and near-fatal asthma attacks in South Australia.

Authors:  D A Campbell; G McLennan; J R Coates; P A Frith; P A Gluyas; K M Latimer; C G Luke; A J Martin; D M Roder; R E Ruffin
Journal:  Eur Respir J       Date:  1994-03       Impact factor: 16.671

10.  A case-control study of deaths from asthma.

Authors:  H H Rea; R Scragg; R Jackson; R Beaglehole; J Fenwick; D C Sutherland
Journal:  Thorax       Date:  1986-11       Impact factor: 9.139

View more
  3 in total

1.  Insights into frequent asthma exacerbations from a primary care perspective and the implications of UK National Review of Asthma Deaths recommendations.

Authors:  Jieqiong Freda Yang; Rekha Chaudhuri; Neil C Thomson; Nitish Ramparsad; Hugh O'Pray; Stephen Barclay; Sean MacBride-Stewart; Craig McCallum; Varun Sharma; Charles McSharry; Dianne Murray; Malcolm Shepherd; Wai-Ting Nicola Lee
Journal:  NPJ Prim Care Respir Med       Date:  2018-09-19       Impact factor: 2.871

2.  At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations.

Authors:  Jane R Smith; Stanley Musgrave; Estelle Payerne; Michael Noble; Erika J Sims; Allan B Clark; Garry Barton; Hilary Pinnock; Aziz Sheikh; Andrew M Wilson
Journal:  Trials       Date:  2018-08-29       Impact factor: 2.279

3.  Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis.

Authors:  Mark L Levy; Alison Hardwell; Eddie McKnight; John Holmes
Journal:  Prim Care Respir J       Date:  2013-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.